Who is sponsoring NCT04900220?

NCT04900220 is sponsored by West Virginia University.

What condition does NCT04900220 study?

NCT04900220 studies Trigger Finger.

What drugs are being tested in NCT04900220?

Interventions: Betamethasone, Methylprednisolone.

What is the status of NCT04900220?

NCT04900220 is currently COMPLETED.

Last reviewed 2023-06-23 · How we verify

Differences in Flare Reaction Incidence and Intensity Following Trigger Finger Injections

NCT04900220 PHASE4 COMPLETED Results posted

Two common corticosteroids used for trigger finger treatment are betamethasone and methylprednisolone. Both injections are effective in treating trigger finger and the decision of which to use in treatment is currently a matter of the current practice and physician preference. The goal through this randomized trial is to see whether there is a difference between these two corticosteroids in inducing flare reactions and if there are any differences in the peak level of pain and their duration. Findings indicating a statistically significant difference in the incidence and/or intensity of the flare reactions would be clinically significant and would be evidence supporting the switch of current practice to one corticosteroid over the other.

Details

Lead sponsor	West Virginia University
Phase	PHASE4
Status	COMPLETED
Enrolment	66
Start date	Wed Sep 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Apr 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Trigger Finger

Interventions

Betamethasone
Methylprednisolone

Countries

United States